Brainscape's Knowledge GenomeTM

Browse over 1 million classes created by top students, professors, publishers, and experts.


See full index

Drugs > Copy of Immunosuppressants and Drug Endings - Sheet1 > Flashcards

Copy of Immunosuppressants and Drug Endings - Sheet1 Flashcards

1
Q

Cyclosporine

A
  1. Post-transplant immunosuppression; select autoimmune disorders
  2. Binds to cyclophilins. Complex blocks differentiation and activation of Tcells by inhibiting calcineurin–> preventing production of IL-2 and its receptor
  3. Nephrotoxicity, hypertension, hyperlipidemia, hyperglycemia, tremor, gingival hyperplasia, hirsutism
  4. Think old man with diabetes who wants to look good for his date so he put in dentures and got hair plugs: old (renal failure, HTN, cholesterol), diabetes (hyperglycemia), dentures (gum hyperplasia), hair plugs (hirsutism, and he is taking the drug because of his hair transplant)
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
1
Q

Tacrolimus (FK-506)

A
  1. Post- organ transplant immunosuppression; POTENT
  2. Binds to FK protein->inhibiting calcineurin->preventing IL-2
  3. Nephrotoxicity, hypertension, hyperlipidemia, hyperglycemia, tremor
  4. Think old with diabetes who is nervous because he is super sick: old (renal failure, HTN, cholesterol), diabetes (hyperglycemia), nervous (tremor), super sick (strong immunosuppressant)
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
2
Q

Sirolimus (rapamycin)

A
  1. Immunosuppression post-KIDNEY transplant (Give with cyclosporine); used with drug-eluting stents
  2. Inhibits mTOR. Decreased cell proliferation in response to IL-2
  3. Hyperlipidemia, thrombocytopenia, leukopenia
  4. SIROlimus= SERIOUS complications: immunosuppression
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
3
Q

Azathioprine

A
  1. Immunosuppression post-KIDNEY transplant; autoimmune disorders (including glomerulonephritis and hemolytic anemia)
  2. Antimetabolite. precursor of 6-MP-> decreased synthesis of nucleic acids. Toxic to proliferating lymphocytes.
  3. Bone marrow suppression.
  4. Active metabolite (mercaptopurine) is metabolized by XO so more toxic when given with Allopurinol
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
4
Q

Muromonab-CD3 (OKT3)

A
  1. Immunosuppression post-KIDNEY transplant
  2. Monoclonal antibody to CD3 on T-cells. Blocks interaction with CD3 protein responsible for T-cell signal transduction
  3. Cytokine release syndrome, hypersensitivity reaction
  4. Antibodies= hypersensitivity, hypersensitivity= cytokine release -nab= monocolonal antibody therapy (usually)
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
5
Q

Recombinant Cytokines

A

Aldesleukin (interleukin-2) Epoetin alfa (erythropoietin) Filgrastim (CSF-G) Sargramostim (CSF-GM) Alpha-Interferon Beta-Interferon Gamma-Interferon Oprelvekin (interleukin-11) Thrombopoietin

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
6
Q

Aldesleukin

A
  1. Renal cell carcinoma Metastatic Melanoma
  2. Cytokine: Interleukin-2 MOA: increases helper, cytotoxic, and regulatory T cells
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
7
Q

Epoetin alfa

A
  1. Anemias (esp in renal failure)
  2. Cytokine: Erythropoietin MOA: Stimulates Erythrocyte replication
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
8
Q

Filgrastim

A
  1. Recovery of bone marrow
  2. G-CSF (Granulocyte Colony Stimulating Factor)
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
9
Q

Sargramostim (CSF-GM)

A
  1. Recovery of bone marrow
  2. GM-CSF (Granulocyte-Macrophage Colony Stimulating Factor)
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
10
Q

Alpha-Interferon

A
  1. Hepatitis B and C, Kaposi’s Sarcoma, Leukemia, Malignant Melanoma
  2. Inhibit viral protein synthesis and activates NK cells to kill virally infected cells
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
11
Q

Beta-Interferon

A

Multiple Sclerosis

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
12
Q

Gamma-Interferon

A
  1. Chronic Granulomatous disease
  2. Activates macrophages and Th1 cells Suppresses Th2 cells.
  3. (G)amma = (G)ranulomatous
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
13
Q

Oprelvekin

A
  1. Thrombocytopenia
  2. IL-11
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
14
Q

Thrombopoietin

A

Thrombocytopenia

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
15
Q

Muromonab-CD3 (OKT3)

A
  1. Immunosuppression post-KIDNEY transplant
  2. Monoclonal antibody to CD3 on T-cells. Blocks interaction with CD3 responsible for T-cell signal transduction
  3. Cytokine release syndrome, hypersensitivity reaction
  4. Antibodies= hypersensitivity, hypersensitivity= cytokine release -nab= monocolonal antibody therapy (usually)
16
Q

Digoxin Immune Fab

A

Target: Digoxin Use: Antidote for Digoxin toxicity

16
Q

Infliximab

A

Target: TNF-alpha Use: Crohn’s Disease, Rheumatoid arthritis, psoriatic arthritis, ankylosing spondylitis

17
Q

Adalimumab

A

Target: TNF-alpha Use: Crohn’s Disease, Rheumatoid arthritis, psoriatic arthritis

18
Q

Abciximab

A

Target: Glycoprotien IIb/IIIa Use: Prevent cardiac ischemia in unstable angina and patients treated with percutaneous coronary intervention

MOA: Prevents platelet aggregation by inhibiting the platelet-GIIb/IIIa-fibrinogen bonds

19
Q

Trastuzumab (Herceptin)

A

Target: HER2 Use: HER2 overexpressing breast cancer

20
Q

Rituximab

A

Target: CD20 Use: B-cell non-Hodgkin’s lymphoma

21
Q

Omalizumab

A

Target: IgE Use: Additional treatment for severe asthma

Drugs (20 decks)

Brainscape helps you reach your goals faster, through stronger study habits.
© 2024 Bold Learning Solutions. Terms and Conditions